Publication | Closed Access

Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

Transplantation OutcomeHematological MalignancyTransplantationMedicineMixed-phenotype Acute LeukemiaHematologyImmunologyPathologyImatinib-based TreatmentBlood TransplantationOncologyCell TransplantationCancer Research